Professor and Chair of Pathology and Laboratory Medicine at the University of Rochester Medical Center, Dr. Smoller is a widely published and respected clinician, teacher, and international expert in dermatopathology.
He finished undergraduate studies at Dartmouth, earning his medical degree from the University of Cincinnati before completing an internship and anatomic and clinical pathology residency (including a turn as chief resident) at Boston's Beth Israel Hospital/Harvard Medical School. In 1987, he went on to a fellowship in dermatopathology at New York Hospital/Cornell University Medical Center.
Dr. Smoller's career has canvassed medical schools affiliated with Harvard, Stanford, Cornell, and the University of Arkansas. More recently, he served a term as executive vice president and secretary-treasurer for the 10,000-member United States and Canadian Academy of Pathology while simultaneously holding a faculty post at both Georgia Regents University (formerly Georgia Health Sciences University) and the Emory University School of Medicine.
Dr. Smoller belongs to a number of professional societies, including the American Society of Dermatopathology, where he took a turn as president and as a board member; the American Society of Clinical Pathologists; and the College of American Pathologists. Smoller spent five years as editor-in-chief of the Journal of Cutaneous Pathology and is frequently tapped for input on editorial boards for other preeminent journals in dermatology, pathology, and dermatopathology. Dr. Smoller has authored more than 200 peer-reviewed articles in leading journals plus 13 textbooks.
His primary research interests revolve around cutaneous T cell lymphoma and the role of immunopathology as a diagnostic tool.
Brendan F. Boyce, M.D. is Professor of Pathology and Laboratory Medicine and Vice Chair of Anatomic Pathology at the University of Rochester Medical Center. Dr. Boyce received his medical degree from the University of Glasgow Medical School in Scotland. He completed his pathology residency training at the Royal Infirmary in Glasgow, Scotland and is board certified in Anatomic Pathology by the American Board of Pathology. Dr. Boyce is a diagnostic surgical pathologist with a subspecialty interest in bone and soft tissue pathology and served as the Director of Surgical Pathology from 1999-2007.
Dr. Boyce is an internationally recognized expert in bone biology, osteoporosis and metabolic bone disease. His research laboratory studies regulatory mechanisms controlling osteoblast and osteoclast function, in particular where there is the potential of opening up new therapeutic pathways for preventing or treating osteoporosis.
Neil Blumberg, M.D. is Vice Chair of the URMC Clinical Labs and the Director of the Transfusion Medicine Unit, Blood Bank and Stem Cell Storage Facility and Professor of Pathology and Laboratory Medicine at the University of Rochester Medical Center. Dr. Blumberg received his medical degree from the Yale University School of Medicine. He completed his pathology residency training at Yale-New Haven Hospital and is board certified in Clinical Pathology by the American Board of Pathology.
Dr. Blumberg has worked to enhance the quality, safety and efficiency of transfusion services at Strong Memorial Hospital and across the broader medical community. His long-standing clinical and research interests focus on immune cytopenias, supportive care for patients with hematologic malignancies and the immunologic sequel of transfusion therapy.
Scott A. Kirkley, M.D. is Vice Chair for Pathology Education, Associate Director of the Transfusion Medicine Service and Program Director of the URMC Pathology Residency Training Program. He serves as Associate Professor of Pathology and Laboratory Medicine. His clinical interests include establishing transfusion protocols and helping coordinate laboratory services in support of organ transplantation programs at Strong Memorial Hospital. He is accredited in Blood Banking and Transfusion Medicine, Anatomic Pathology, and Clinical Pathology by the American Board of Pathology; and in Internal Medicine by American Board of Internal Medicine.
He received his medical degree at SUNY Upstate Medical Center, Syracuse, after earning a bachelor’s degree in Biochemistry at Syracuse University. His post-doctoral training includes a fellowship in Transfusion Medicine at Hoxworth Blood Center in Cincinnati, OH, a residency in Anatomic and Clinical Pathology at Deaconess Hospital in Boston, MA, and a residency and internship in Internal Medicine at Danbury Hospital in Danbury, CT.
Dr. Kirkley’s research has focused on the suppressive effects of allogeneic (homologous) blood transfusion on the immune system, and comparing the effects of allogeneic, autologous, and leukoreduced transfusions on immune function.
Dr. De Las Casas is the Director of Cytopathology at the University of Rochester Medical Center.
Prior to joining URMC in 2016, he held faculty appointments in the departments of pathology at the University of Wisconsin, University of Arkansas for Medical Sciences, Texas Tech University Health Science Center, and University of Toledo Medical Center.
He is board-certified in anatomic and clinical pathology, as well as cytopathology. He has an excellent record of peer-reviewed publications, teaching, and professional activities that focus on integrating cytopathology and surgical pathology practices using a personalized multidisciplinary clinical approach.
Dr. De Las Casas diagnostic approach uses cytopathology as the first step in the pathologic diagnosis of tumors. He has performed more than 800 ultrasound-guided fine-needle aspiration biopsies and has founded two different FNA clinics.
He is dedicated to promoting and implementing the concept of interventional cytopathology both in his independent practice and as a consultant to referring clinicians.